Return On Equity of VYNE Therapeutics Inc. from 30 Sep 2018 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
VYNE Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Jun 2025.
  • VYNE Therapeutics Inc. Return On Equity for the quarter ending 30 Jun 2025 was -78%, a 76% decline year-over-year.
  • VYNE Therapeutics Inc. annual Return On Equity for 2024 was -58%, a 26% increase from 2023.
  • VYNE Therapeutics Inc. annual Return On Equity for 2023 was -79%, a 49% decline from 2022.
  • VYNE Therapeutics Inc. annual Return On Equity for 2022 was -53%, a 50% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

VYNE Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -78% -34% -76% 01 Apr 2025 30 Jun 2025
Q1 2025 -72% -14% -24% 01 Jan 2025 31 Mar 2025
Q4 2024 -58% +21% +26% 01 Oct 2024 31 Dec 2024
Q3 2024 -44% +105% +71% 01 Jul 2024 30 Sep 2024
Q2 2024 -44% +78% +64% 01 Apr 2024 30 Jun 2024
Q1 2024 -58% +34% +37% 01 Jan 2024 31 Mar 2024
Q4 2023 -79% -26% -49% 01 Oct 2023 31 Dec 2023
Q3 2023 -149% -98% -189% 01 Jul 2023 30 Sep 2023
Q2 2023 -122% -53% -76% 01 Apr 2023 30 Jun 2023
Q1 2023 -92% -11% -14% 01 Jan 2023 31 Mar 2023
Q4 2022 -53% +54% +50% 01 Oct 2022 31 Dec 2022
Q3 2022 -52% +77% +60% 01 Jul 2022 30 Sep 2022
Q2 2022 -69% +69% +50% 01 Apr 2022 30 Jun 2022
Q1 2022 -81% +294% +78% 01 Jan 2022 31 Mar 2022
Q4 2021 -107% +342% +76% 01 Oct 2021 31 Dec 2021
Q3 2021 -129% +359% +74% 01 Jul 2021 30 Sep 2021
Q2 2021 -139% +337% +71% 01 Apr 2021 30 Jun 2021
Q1 2021 -375% -169% -82% 01 Jan 2021 31 Mar 2021
Q4 2020 -448% -298% -198% 01 Oct 2020 31 Dec 2020
Q3 2020 -488% -382% -362% 01 Jul 2020 30 Sep 2020
Q2 2020 -476% -407% -594% 01 Apr 2020 30 Jun 2020
Q1 2020 -207% -161% -355% 01 Jan 2020 31 Mar 2020
Q4 2019 -151% -114% -312% 01 Oct 2019 31 Dec 2019
Q3 2019 -106% -74% -230% 01 Jul 2019 30 Sep 2019
Q2 2019 -68% 01 Apr 2019 30 Jun 2019
Q1 2019 -45% 01 Jan 2019 31 Mar 2019
Q4 2018 -37% 01 Oct 2018 31 Dec 2018
Q3 2018 -32% 01 Jul 2018 30 Sep 2018

VYNE Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -58% +21% +26% 01 Jan 2024 31 Dec 2024
2023 -79% -26% -49% 01 Jan 2023 31 Dec 2023
2022 -53% +54% +50% 01 Jan 2022 31 Dec 2022
2021 -107% +342% +76% 01 Jan 2021 31 Dec 2021
2020 -448% -266% -147% 01 Jan 2020 31 Dec 2020
2019 -182% -129% -245% 01 Jan 2019 31 Dec 2019
2018 -53% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.